$MOS

Mosaic’s Quarterly Earnings Preview: What You Need to Know

The Mosaic Company (MOS) is set to report Q2 2026 earnings on Aug. 4 after market close. Analysts expect diluted EPS of $0.11, down from $0.51 a year earlier, and forecast full-year EPS of $0.83 for 2026 and $1.83 for 2027. MOS has missed EPS estimates in 3 of 4 quarters. The stock is rated mostly Hold, with a mean price target of $26.11.

Original reporting
Published Jul 17, 2026, 7:30 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jul 17, 2026, 8:23 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Mosaic’s Quarterly Earnings Preview: What You Need to Know — source image
Decision brief

The 30-second read

$MOSNeutralMed
01

Why it matters

The key trade input is the consensus EPS expectation ($0.11) versus the prior-year quarter ($0.51), alongside a history of missing estimates and described demand/credit headwinds.

02

Market read

This is an event-driven setup for MOS into its Aug. 4 earnings print, with consensus pointing to a steep EPS decline and continued caution from analysts.

03

What to watch

The preview does not include guidance details, margin/cost drivers, or any balance-sheet/liquidity updates that could dominate the earnings reaction.

Relevance 4/10Novelty 4/10Timing: Ahead of MOS Q2 2026 earnings on Tuesday, Aug. 4 after the close.

Background

Mosaic produces concentrated phosphate and potash crop nutrients and is expected to report Q2 2026 earnings Aug. 4 after the close.

Company-level read

Ticker impact

$MOSNeutralMedium confidence
Context

Mosaic is set to report Q2 2026 earnings Aug. 4 after the close, with consensus EPS expected at $0.11 and a sharp YoY decline.

Expected impact

Volatility likely increases into the Aug. 4 after-hours print; direction depends on whether results and guidance offset the expected EPS decline.

Evidence & confidence

The article provides consensus EPS expectations, recent beat/miss history, and qualitative demand/credit pressures, but it does not disclose any new company-specific datapoint beyond the preview.

Market effects

Highlights ongoing phosphate and potash demand softness and competitive/import pressure, which can influence sentiment across fertilizer names.

Emphasizes North America demand weakness and Brazil credit tightening, relevant to regional fertilizer demand expectations.

Points to Chinese import competition affecting global phosphate pricing dynamics.

Counterpoint

If management commentary shows demand stabilizing or cost/production issues easing, the stock could outperform the bearish EPS read-through despite the low consensus number.

Key entities

  • The Mosaic Company

    Subject of the earnings preview, with Q2 2026 earnings expected Aug. 4 after the close.

  • MOS

    Mosaic’s US-listed equity referenced throughout the preview.

Related articles

$MOSMed

S&P downgrades Mosaic outlook on high costs, weak cash flow

S&P Global Ratings downgraded Mosaic Co.’s outlook to negative from stable while keeping its BBB issuer credit rating. It expects funds from operations to debt below 20% in 2026. It projects adjusted EBITDA around $1.6B in 2026 vs $2.6B in 2025, citing high sulfur and ammonia costs, weaker phosphate margins, and negative discretionary cash flow of $400M to $500M.

$MOSLow

MOSAIC CO (MOS): Results of Operations and Financial Condition

MOSAIC CO (MOS) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.2 3 performancedataq22026-ex992.htm EX-99.2 - PERFORMANCE DATA Document Exhibit 99.2 The Mosaic Company Selected Calendar Quarter Financial Information (Unaudited) Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026 Consolidated data (in millions, except per sha

$JANMedAI 8/10

JAN Q2 Earnings Call Highlights

Janus Living (NYSE:JAN) reported sequential same-store NOI margin down 40 bps, citing seasonality. Occupancy rose for independent living but fell for skilled nursing. The company acquired two communities for $105M, sold one for $23M, and completed $1B more acquisitions post-quarter. It raised 2026 FFO guidance to $0.95-$0.98 and same-store adjusted NOI growth to 13%-17%.

$JOBYMedAI 8/10

Joby Aviation Q2 Earnings Call Highlights

Joby Aviation (NYSE:JOBY) raised full-year revenue guidance to $115 million to $125 million from $105 million to $115 million. Q2 cash use was about $202 million and GAAP net loss was $245 million, including a $108 million non-cash warrant and earn-out fair value change. For 2H 2026, it expects $385 million to $415 million cash use. The company said aircraft availability is a key constraint on Blade routes and outlined manufacturing, infrastructure, and JV plans with Toyota.

$JHXMedAI 8/10

James Hardie Industries Q1 Earnings Call Highlights

James Hardie (NYSE:JHX) said about one-third of fiber-cement growth came from strategic initiatives, one-third from prior-year destocking comparisons, and the rest from price and mix. June sell-through rose 19%. Deck, Rail & Accessories sales fell 5% to $305.1M with 27.1% Adjusted EBITDA margin. Q2 net sales forecast $1.485B-$1.575B and FY2027 outlook raised; FCF Q1 was $254M and it redeemed $400M notes.

$IXMed

Orix Corp Ads Q1 Earnings Call Highlights

ORIX (NYSE: IX) discussed Q1 results and outlook on an earnings call, including potential Q3 Kioxia sale and valuation losses tied to Kioxia’s end-September share price. ORIX shifted its dividend basis to adjusted profits, targeting an interim dividend of JPY 107.27 per share and full-year JPY 187.36. It reported JPY 115.7B capital gains and about JPY 300B capital-recycling inflows, and continued a JPY 250B buyback.